Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral Tongue Cancer in a Patient with Fanconi Anemia: A Case Report and Literature Review. | Cancer Manag Res | 2021 | 33883933 | PubTator, text mining | PubMed |
| Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes. | Haematologica | 2021 | 33882640 | PubTator, text mining | PubMed |
MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus). | J Transl Med | 2021 | 33858417 | PubTator, text mining | PubMed |
| Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer. | Sci Rep | 2021 | 33854152 | PubTator, text mining | PubMed |
| Comprehensive tumor molecular profile analysis in clinical practice. | BMC Med Genomics | 2021 | 33853586 | PubTator, text mining | PubMed |
| Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients. | Ann Transl Med | 2021 | 33842585 | PubTator, text mining | PubMed |
| Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer. | Eur J Hum Genet | 2021 | 33840814 | PubTator, text mining | PubMed |
| Understanding the cellular origin and progression of esophageal cancer using esophageal organoids. | Cancer Lett | 2021 | 33838281 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma. | Diagn Pathol | 2021 | 33832503 | PubTator, text mining | PubMed |
| Case Report: Single Dose Anti-PD1 in a Patient With Metastatic Melanoma and Cardiac Allograft. | Front Immunol | 2021 | 33828564 | PubTator, text mining | PubMed |
| Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer. | Expert Opin Pharmacother | 2021 | 33827356 | PubTator, text mining | PubMed |
| Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference. | J Clin Immunol | 2021 | 33822308 | PubTator, text mining | PubMed |
| Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. | Clin Cancer Res | 2021 | 33820782 | PubTator, text mining | PubMed |
| Regulation of Circular RNA CircNFATC3 in Cancer Cells Alters Proliferation, Migration, and Oxidative Phosphorylation. | Front Cell Dev Biol | 2021 | 33816459 | PubTator, text mining | PubMed |
| Astrocyte Clocks and Glucose Homeostasis. | Front Endocrinol (Lausanne) | 2021 | 33815298 | PubTator, text mining | PubMed |
| The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 33809651 | PubTator, text mining | PubMed |
| Additional Tissue Sampling Trials Did Not Change Our Thyroid Practice. | Cancers (Basel) | 2021 | 33809394 | PubTator, text mining | PubMed |
| Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2021 | 33808193 | PubTator, text mining | PubMed |
| Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues. | Cells | 2021 | 33808130 | PubTator, text mining | PubMed |
| Disentangling Species Delineation and Guiding Conservation of Endangered Magnolias in Veracruz, Mexico. | Plants (Basel) | 2021 | 33807445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=73